NPC1L1
Basic information
Region (hg38): 7:44512535-44541330
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ezetimibe, nonresponse to | AD/AR | Pharmacogenomic | Variants may have pharmacogenomic relevance and medication selection may be affected in patients with variants | General | 15679830; 20686565 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPC1L1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 17 | ||||
missense | 75 | 13 | 95 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 2 | |||||
Total | 0 | 0 | 75 | 24 | 15 |
Variants in NPC1L1
This is a list of pathogenic ClinVar variants found in the NPC1L1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-44513457-C-T | not specified | Likely benign (Feb 14, 2023) | ||
7-44513458-G-A | not specified | Uncertain significance (Oct 20, 2021) | ||
7-44513513-A-C | not specified | Uncertain significance (Oct 06, 2021) | ||
7-44513605-C-T | NPC1L1-related disorder | Benign (Feb 21, 2019) | ||
7-44513634-G-A | not specified | Uncertain significance (Mar 29, 2022) | ||
7-44513639-A-G | not specified | Benign (Mar 29, 2016) | ||
7-44513641-C-T | not specified | Likely benign (Aug 30, 2022) | ||
7-44513654-GGA-G | NPC1L1-related disorder | Benign (Feb 21, 2019) | ||
7-44515806-C-T | not specified | Uncertain significance (May 21, 2024) | ||
7-44515807-G-A | not specified | Benign (Mar 29, 2016) | ||
7-44515822-G-A | Likely benign (Jul 01, 2022) | |||
7-44515859-G-C | not specified | Uncertain significance (Jun 05, 2024) | ||
7-44515869-G-C | not specified | Uncertain significance (Sep 20, 2023) | ||
7-44515911-C-A | not specified | Uncertain significance (Feb 06, 2023) | ||
7-44515911-C-T | not specified | Uncertain significance (Mar 26, 2024) | ||
7-44515974-T-G | not specified | Benign (Mar 29, 2016) | ||
7-44516085-G-T | not specified | Uncertain significance (Apr 09, 2024) | ||
7-44516100-A-T | Ezetimibe response • not specified | Likely benign (Mar 29, 2016) | ||
7-44516704-G-A | not specified | Uncertain significance (Jan 18, 2022) | ||
7-44516768-T-C | not specified | Uncertain significance (Nov 14, 2023) | ||
7-44516876-G-T | not specified | Uncertain significance (Jul 25, 2023) | ||
7-44516910-C-G | Likely benign (May 25, 2018) | |||
7-44517233-G-T | not specified | Uncertain significance (May 17, 2023) | ||
7-44517235-C-A | not specified | Uncertain significance (Oct 30, 2023) | ||
7-44517235-C-G | Benign (Jun 14, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPC1L1 | protein_coding | protein_coding | ENST00000289547 | 20 | 28781 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.31e-20 | 0.507 | 125488 | 0 | 260 | 125748 | 0.00103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.409 | 729 | 761 | 0.958 | 0.0000484 | 8765 |
Missense in Polyphen | 203 | 234.21 | 0.86676 | 2817 | ||
Synonymous | -1.44 | 370 | 336 | 1.10 | 0.0000222 | 2903 |
Loss of Function | 1.94 | 39 | 54.4 | 0.716 | 0.00000309 | 579 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00195 | 0.00194 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00671 | 0.00671 |
Finnish | 0.0000468 | 0.0000462 |
European (Non-Finnish) | 0.000636 | 0.000633 |
Middle Eastern | 0.00671 | 0.00671 |
South Asian | 0.000393 | 0.000392 |
Other | 0.000654 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a major role in cholesterol homeostasis. Is critical for the uptake of cholesterol across the plasma membrane of the intestinal enterocyte. Is the direct molecular target of ezetimibe, a drug that inhibits cholesterol absorption. Lack of activity leads to multiple lipid transport defects. The protein may have a function in the transport of multiple lipids and their homeostasis, and may play a critical role in regulating lipid metabolism. Acts as a negative regulator of NPC2 and down- regulates its expression and secretion by inhibiting its maturation and accelerating its degradation. {ECO:0000269|PubMed:15928087, ECO:0000269|PubMed:22095670}.;
- Pathway
- Fat digestion and absorption - Homo sapiens (human);Vitamin A and Carotenoid Metabolism;C21-steroid hormone biosynthesis and metabolism;Intestinal lipid absorption;Intestinal absorption;Digestion and absorption
(Consensus)
Recessive Scores
- pRec
- 0.187
Intolerance Scores
- loftool
- 0.0150
- rvis_EVS
- 1.38
- rvis_percentile_EVS
- 94.54
Haploinsufficiency Scores
- pHI
- 0.129
- hipred
- N
- hipred_score
- 0.421
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.319
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Npc1l1
- Phenotype
- liver/biliary system phenotype; digestive/alimentary phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- cholesterol biosynthetic process;intestinal cholesterol absorption;cholesterol transport;lipoprotein metabolic process;response to drug;cellular response to sterol depletion;intestinal lipid absorption
- Cellular component
- plasma membrane;apical plasma membrane;cytoplasmic vesicle membrane;brush border membrane;spanning component of plasma membrane
- Molecular function
- protein binding;drug binding;Rab GTPase binding;myosin V binding